Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
112,508,491
-
Total 13F shares
-
120,390,588
-
Share change
-
+3,984,687
-
Total reported value
-
$3,423,902,136
-
Put/Call ratio
-
2772%
-
Price per share
-
$28.44
-
Number of holders
-
135
-
Value change
-
+$122,883,175
-
Number of buys
-
67
-
Number of sells
-
54
Institutional Holders of NewAmsterdam Pharma Co N.V. - COMMON STOCK (NAMS) as of Q3 2025
As of 30 Sep 2025,
NewAmsterdam Pharma Co N.V. - COMMON STOCK (NAMS) was held by
135 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
120,390,588 shares.
The largest 10 holders included
Frazier Life Sciences Management, L.P., Bain Capital Life Sciences Investors, LLC, RA CAPITAL MANAGEMENT, L.P., Capital World Investors, FCPM III SERVICES B.V., VIKING GLOBAL INVESTORS LP, FMR LLC, DEERFIELD MANAGEMENT COMPANY, L.P., JENNISON ASSOCIATES LLC, and WELLINGTON MANAGEMENT GROUP LLP.
This page lists
135
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.